Article Details

Revolo Biotherapeutics Announces US FDA Approval of IND Application for Phase 2 Trial of '1104 ...

Retrieved on: 2021-06-23 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Revolo Biotherapeutics Announces US FDA Approval of IND Application for Phase 2 Trial of '1104 .... View article details on hiswai:

Excerpt

Our goal is to prevent the inflammation associated with EoE and do this without suppressing the immune system. This approach is novel and unlike ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo